Lilly Loses Bid to End Revived Zyprexa UK Patent Case

Eli Lilly, whose best-selling schizophrenia drug Zyprexa survived a United Kingdom court challenge by generic makers two years ago, lost a bid to dismiss another lawsuit over the medicine’s patent in Britain.
Indianapolis Business Journal